Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 1019-6439 Online ISSN: 1791-2423
Journal Cover
July-2018 Volume 53 Issue 1

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2018 Volume 53 Issue 1

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma

  • Authors:
    • Qi Cao
    • Hailong Ruan
    • Keshan Wang
    • Zhengshuai Song
    • Lin Bao
    • Tianbo Xu
    • Haibing Xiao
    • Cheng Wang
    • Gong Cheng
    • Junwei Tong
    • Xiangui Meng
    • Di Liu
    • Hongmei Yang
    • Ke Chen
    • Xiaoping Zhang
  • View Affiliations / Copyright

    Affiliations: Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China, Department of Pathogenic Biology, School of Basic Medicine, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China
    Copyright: © Cao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 137-147
    |
    Published online on: April 26, 2018
       https://doi.org/10.3892/ijo.2018.4384
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Clear cell renal cell carcinoma (ccRCC) is the most common renal malignancy in adults, the incidence of which continues to increase. The lipid droplet protein perilipin 2 (PLIN2), which was originally considered an RNA transcript, is markedly expressed during adipocyte differentiation. In addition, it has been observed to be elevated in numerous types of cancer, including ccRCC; however, its essential function remains unclear in ccRCC. The present study examined the expression of PLIN2 in ccRCC, and aimed to determine the association between PLIN2 expression and patient survival. The present study mined the transcriptional, clinicopathological and survival data of PLIN2 in patients with ccRCC through The Cancer Genome Atlas. The expression levels of PLIN2 were also detected in human ccRCC tissues and cell lines by western blotting and immunohistochemistry, and its biological role was identified by functional analysis. The results demonstrated that PLIN2 was predominantly elevated in RCC tissues and cells. In addition, the expression levels of PLIN2 were significantly associated with various clinicopathological factors, and high PLIN2 expression was associated with a good prognosis. The results of a multivariate analysis demonstrated that high PLIN2 expression was an independent prognostic indicator of overall survival (hazard ratio, 0.586; P=0.001). Furthermore, PLIN2 knockdown promoted proliferation of ccRCC cells, and enhanced cell invasion and migration. These results suggested that PLIN2 may be considered a novel prognostic factor in ccRCC and a specific diagnostic indicator for patients with ccRCC. Furthermore, it could be a potential novel target for the clinical treatment of ccRCC.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Siegel RL, Miller KD and Jemal A: Cancer statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI

3 

Moch H, Cubilla AL, Humphrey PA, Reuter VE and Ulbright TM: The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, penile, and testicular Tumours. Eur Urol. 70:93–105. 2016. View Article : Google Scholar : PubMed/NCBI

4 

Novara G, Ficarra V, Antonelli A, Artibani W, Bertini R, Carini M, Cosciani Cunico S, Imbimbo C, Longo N, Martignoni G, et al: SATURN Project-LUNA Foundation: Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: Are further improvements needed? Eur Urol. 58:588–595. 2010. View Article : Google Scholar : PubMed/NCBI

5 

Gong J, Maia MC, Dizman N, Govindarajan A and Pal SK: Metastasis in renal cell carcinoma: Biology and implications for therapy. Asian J Urol. 3:286–292. 2016. View Article : Google Scholar : PubMed/NCBI

6 

Pichler M, Hutterer GC, Chromecki TF, Jesche J, Kampel-Kettner K, Rehak P, Pummer K and Zigeuner R: External validation of the Leibovich prognosis score for nonmetastatic clear cell renal cell carcinoma at a single European center applying routine pathology. J Urol. 186:1773–1777. 2011. View Article : Google Scholar : PubMed/NCBI

7 

Albiges L, Fay AP, Xie W, Krajewski K, McDermott DF, Heng DY, Dariane C, DeVelasco G, Lester R, Escudier B, et al: Efficacy of targeted therapies after PD-1/PD-L1 blockade in metastatic renal cell carcinoma. Eur J Cancer. 51:2580–2586. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Oudard S and Vano Y: The role of rechallenge with targeted therapies in metastatic renal-cell carcinoma. Curr Opin Urol. 25:402–410. 2015. View Article : Google Scholar : PubMed/NCBI

9 

Zanardi E, Verzoni E, Grassi P, Necchi A, Giannatempo P, Raggi D, De Braud F and Procopio G: Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma. Ther Adv Urol. 7:152–161. 2015. View Article : Google Scholar : PubMed/NCBI

10 

Bickel PE, Tansey JT and Welte MA: PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores. Biochim Biophys Acta. 1791:419–440. 2009. View Article : Google Scholar : PubMed/NCBI

11 

Kimmel AR, Brasaemle DL, McAndrews-Hill M, Sztalryd C and Londos C: Adoption of PERILIPIN as a unifying nomenclature for the mammalian PAT-family of intracellular lipid storage droplet proteins. J Lipid Res. 51:468–471. 2010. View Article : Google Scholar :

12 

Brasaemle DL: Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J Lipid Res. 48:2547–2559. 2007. View Article : Google Scholar : PubMed/NCBI

13 

Ducharme NA and Bickel PE: Lipid droplets in lipogenesis and lipolysis. Endocrinology. 149:942–949. 2008. View Article : Google Scholar : PubMed/NCBI

14 

Londos C, Sztalryd C, Tansey JT and Kimmel AR: Role of PAT proteins in lipid metabolism. Biochimie. 87:45–49. 2005. View Article : Google Scholar : PubMed/NCBI

15 

Lu X, Gruia-Gray J, Copeland NG, Gilbert DJ, Jenkins NA, Londos C and Kimmel AR: The murine perilipin gene: The lipid droplet-associated perilipins derive from tissue-specific, mRNA splice variants and define a gene family of ancient origin. Mamm Genome. 12:741–749. 2001. View Article : Google Scholar : PubMed/NCBI

16 

Miura S, Gan JW, Brzostowski J, Parisi MJ, Schultz CJ, Londos C, Oliver B and Kimmel AR: Functional conservation for lipid storage droplet association among Perilipin, ADRP, and TIP47 (PAT)-related proteins in mammals, Drosophila, and Dictyostelium. J Biol Chem. 277:32253–32257. 2002. View Article : Google Scholar : PubMed/NCBI

17 

Thiele C and Spandl J: Cell biology of lipid droplets. Curr Opin Cell Biol. 20:378–385. 2008. View Article : Google Scholar : PubMed/NCBI

18 

Zehmer JK, Huang Y, Peng G, Pu J, Anderson RG and Liu P: A role for lipid droplets in inter-membrane lipid traffic. Proteomics. 9:914–921. 2009. View Article : Google Scholar : PubMed/NCBI

19 

Walther TC and Farese RV Jr: Lipid droplets and cellular lipid metabolism. Annu Rev Biochem. 81:687–714. 2012. View Article : Google Scholar : PubMed/NCBI

20 

Zhou C, Wang M, Zhou L, Zhang Y, Liu W, Qin W, He R, Lu Y, Wang Y, Chen XZ, et al: Prognostic significance of PLIN1 expression in human breast cancer. Oncotarget. 7:54488–54502. 2016.PubMed/NCBI

21 

Szigeti A, Minik O, Hocsak E, Pozsgai E, Boronkai A, Farkas R, Balint A, Bodis J, Sumegi B and Bellyei S: Preliminary study of TIP47 as a possible new biomarker of cervical dysplasia and invasive carcinoma. Anticancer Res. 29:717–724. 2009.PubMed/NCBI

22 

Jiang HP, Harris SE and Serrero G: Molecular cloning of a differentiation-related mRNA in the adipogenic cell line 1246. Cell Growth Differ. 3:21–30. 1992.PubMed/NCBI

23 

Jiang HP and Serrero G: Isolation and characterization of a full-length cDNA coding for an adipose differentiation-related protein. Proc Natl Acad Sci USA. 89:7856–7860. 1992. View Article : Google Scholar : PubMed/NCBI

24 

Chong BM, Reigan P, Mayle-Combs KD, Orlicky DJ and McManaman JL: Determinants of adipophilin function in milk lipid formation and secretion. Trends Endocrinol Metab. 22:211–217. 2011. View Article : Google Scholar : PubMed/NCBI

25 

Brasaemle DL, Barber T, Wolins NE, Serrero G, Blanchette-Mackie EJ and Londos C: Adipose differentiation-related protein is an ubiquitously expressed lipid storage droplet-associated protein. J Lipid Res. 38:2249–2263. 1997.PubMed/NCBI

26 

Phillips SA, Choe CC, Ciaraldi TP, Greenberg AS, Kong AP, Baxi SC, Christiansen L, Mudaliar SR and Henry RR: Adipocyte differentiation-related protein in human skeletal muscle: Relationship to insulin sensitivity. Obes Res. 13:1321–1329. 2005. View Article : Google Scholar : PubMed/NCBI

27 

Heid HW, Moll R, Schwetlick I, Rackwitz HR and Keenan TW: Adipophilin is a specific marker of lipid accumulation in diverse cell types and diseases. Cell Tissue Res. 294:309–321. 1998. View Article : Google Scholar : PubMed/NCBI

28 

Zhang XD, Li W, Zhang N, Hou YL, Niu ZQ, Zhong YJ, Zhang YP and Yang SY: Identification of adipophilin as a potential diagnostic tumor marker for lung adenocarcinoma. Int J Clin Exp Med. 7:1190–1196. 2014.PubMed/NCBI

29 

Matsubara J, Honda K, Ono M, Sekine S, Tanaka Y, Kobayashi M, Jung G, Sakuma T, Nakamori S, Sata N, et al: Identification of adipophilin as a potential plasma biomarker for colorectal cancer using label-free quantitative mass spectrometry and protein microarray. Cancer Epidemiol Biomarkers Prev. 20:2195–2203. 2011. View Article : Google Scholar : PubMed/NCBI

30 

Mentrikoski MJ, Wendroth SM and Wick MR: Immunohistochemical distinction of renal cell carcinoma from other carcinomas with clear-cell histomorphology: Utility of CD10 and CA-125 in addition to PAX-2, PAX-8, RCCma, and adipophilin. Appl Immunohistochem Mol Morphol. 22:635–641. 2014. View Article : Google Scholar : PubMed/NCBI

31 

Straub BK, Herpel E, Singer S, Zimbelmann R, Breuhahn K, Macher-Goeppinger S, Warth A, Lehmann-Koch J, Longerich T, Heid H, et al: Lipid droplet-associated PAT-proteins show frequent and differential expression in neoplastic steatogenesis. Mod Pathol. 23:480–492. 2010. View Article : Google Scholar : PubMed/NCBI

32 

Yao M, Huang Y, Shioi K, Hattori K, Murakami T, Nakaigawa N, Kishida T, Nagashima Y and Kubota Y: Expression of adipose differentiation-related protein: A predictor of cancer-specific survival in clear cell renal carcinoma. Clin Cancer Res. 13:152–160. 2007. View Article : Google Scholar : PubMed/NCBI

33 

Tolkach Y, Lüders C, Meller S, Jung K, Stephan C and Kristiansen G: Adipophilin as prognostic biomarker in clear cell renal cell carcinoma. Oncotarget. 8:28672–28682. 2017. View Article : Google Scholar : PubMed/NCBI

34 

Qiu B, Ackerman D, Sanchez DJ, Li B, Ochocki JD, Grazioli A, Bobrovnikova-Marjon E, Diehl JA, Keith B and Simon MC: HIF2α-dependent lipid storage promotes endoplasmic reticulum homeostasis in clear-cell renal cell carcinoma. Cancer Discov. 5:652–667. 2015. View Article : Google Scholar : PubMed/NCBI

35 

Ruan H, Li X, Yang H, Song Z, Tong J, Cao Q, Wang K, Xiao W, Xiao H, Chen X, et al: Enhanced expression of caveolin-1 possesses diagnostic and prognostic value and promotes cell migration, invasion and sunitinib resistance in the clear cell renal cell carcinoma. Exp Cell Res. 358:269–278. 2017. View Article : Google Scholar : PubMed/NCBI

36 

Liu R, Qin X, Ji C, Zeng W, Yang Y and Tan W: Pygopus 2 promotes kidney cancer OS-RC-2 cells proliferation and inva-sionin vitroandin vivo. Asian J Urol. 2:151–157. 2015. View Article : Google Scholar : PubMed/NCBI

37 

Cline MS, Craft B, Swatloski T, Goldman M, Ma S, Haussler D and Zhu J: Exploring TCGA pan-cancer data at the UCSC cancer genomics browser. Sci Rep. 3:26522013. View Article : Google Scholar : PubMed/NCBI

38 

Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI

39 

Targett-Adams P, Chambers D, Gledhill S, Hope RG, Coy JF, Girod A and McLauchlan J: Live cell analysis and targeting of the lipid droplet-binding adipocyte differentiation-related protein. J Biol Chem. 278:15998–16007. 2003. View Article : Google Scholar : PubMed/NCBI

40 

Morrissey JJ, Mobley J, Figenshau RS, Vetter J, Bhayani S and Kharasch ED: Urine aquaporin 1 and perilipin 2 differentiate renal carcinomas from other imaged renal masses and bladder and prostate cancer. Mayo Clin Proc. 90:35–42. 2015. View Article : Google Scholar : PubMed/NCBI

41 

Ambrosio MR, Piccaluga PP, Ponzoni M, Rocca BJ, Malagnino V, Onorati M, De Falco G, Calbi V, Ogwang M, Naresh KN, et al: The alteration of lipid metabolism in Burkitt lymphoma identifies a novel marker: Adipophilin. PLoS One. 7:e443152012. View Article : Google Scholar : PubMed/NCBI

42 

Fujimoto M, Matsuzaki I, Yamamoto Y, Yoshizawa A, Warigaya K, Iwahashi Y, Kojima F, Furukawa F and Murata SI: Adipophilin expression in cutaneous malignant melanoma. J Cutan Pathol. 44:228–236. 2017. View Article : Google Scholar

43 

Lucenay KS, Doostan I, Karakas C, Bui T, Ding Z, Mills GB, Hunt KK and Keyomarsi K: Cyclin E associates with the lipogenic enzyme ATP-citrate lyase to enable malignant growth of breast cancer cells. Cancer Res. 76:2406–2418. 2016. View Article : Google Scholar : PubMed/NCBI

44 

Yao M, Tabuchi H, Nagashima Y, Baba M, Nakaigawa N, Ishiguro H, Hamada K, Inayama Y, Kishida T, Hattori K, et al: Gene expression analysis of renal carcinoma: Adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma. J Pathol. 205:377–387. 2005. View Article : Google Scholar : PubMed/NCBI

45 

Targett-Adams P, McElwee MJ, Ehrenborg E, Gustafsson MC, Palmer CN and McLauchlan J: A PPAR response element regulates transcription of the gene for human adipose differentiation-related protein. Biochim Biophys Acta. 1728:95–104. 2005. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Cao Q, Ruan H, Wang K, Song Z, Bao L, Xu T, Xiao H, Wang C, Cheng G, Tong J, Tong J, et al: Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma. Int J Oncol 53: 137-147, 2018.
APA
Cao, Q., Ruan, H., Wang, K., Song, Z., Bao, L., Xu, T. ... Zhang, X. (2018). Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma. International Journal of Oncology, 53, 137-147. https://doi.org/10.3892/ijo.2018.4384
MLA
Cao, Q., Ruan, H., Wang, K., Song, Z., Bao, L., Xu, T., Xiao, H., Wang, C., Cheng, G., Tong, J., Meng, X., Liu, D., Yang, H., Chen, K., Zhang, X."Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma". International Journal of Oncology 53.1 (2018): 137-147.
Chicago
Cao, Q., Ruan, H., Wang, K., Song, Z., Bao, L., Xu, T., Xiao, H., Wang, C., Cheng, G., Tong, J., Meng, X., Liu, D., Yang, H., Chen, K., Zhang, X."Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma". International Journal of Oncology 53, no. 1 (2018): 137-147. https://doi.org/10.3892/ijo.2018.4384
Copy and paste a formatted citation
x
Spandidos Publications style
Cao Q, Ruan H, Wang K, Song Z, Bao L, Xu T, Xiao H, Wang C, Cheng G, Tong J, Tong J, et al: Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma. Int J Oncol 53: 137-147, 2018.
APA
Cao, Q., Ruan, H., Wang, K., Song, Z., Bao, L., Xu, T. ... Zhang, X. (2018). Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma. International Journal of Oncology, 53, 137-147. https://doi.org/10.3892/ijo.2018.4384
MLA
Cao, Q., Ruan, H., Wang, K., Song, Z., Bao, L., Xu, T., Xiao, H., Wang, C., Cheng, G., Tong, J., Meng, X., Liu, D., Yang, H., Chen, K., Zhang, X."Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma". International Journal of Oncology 53.1 (2018): 137-147.
Chicago
Cao, Q., Ruan, H., Wang, K., Song, Z., Bao, L., Xu, T., Xiao, H., Wang, C., Cheng, G., Tong, J., Meng, X., Liu, D., Yang, H., Chen, K., Zhang, X."Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma". International Journal of Oncology 53, no. 1 (2018): 137-147. https://doi.org/10.3892/ijo.2018.4384
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team